-
Jun 10, 2021, 1:48 pm201 ptsAdvisory groups questioned whether the upfront payouts were in the best interests of shareholders The US drugmaker Regeneron, whose Covid treatment was hailed as a “cure” by Donald Trump last year, has come under fire from two influential shareholder advisory groups over “excessive” payouts…
Welcome to Politomix -- the political news wire where left, right and center mix.
Politomix aggregates the day's political news on the web and your mobile device.
